Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies28
  • 7D-0.6%
  • 3M11.5%
  • 1Y-15.9%
  • YTD4.9%

The Biotech is pretty flat in the last 7 days, but CanBas has stood out, gaining 38%. Unfortunately though, the industry is down 16% over the past 12 months. Looking forward, earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Feb 2023JP¥946.6bJP¥186.7b-JP¥24,854,541,000.0039.7x-38.1x5.1x
Sun, 01 Jan 2023JP¥930.2bJP¥186.8b-JP¥24,722,604,000.0044.6x-37.6x5x
Tue, 29 Nov 2022JP¥896.3bJP¥182.1b-JP¥23,614,604,000.0045.3x-38x4.9x
Thu, 27 Oct 2022JP¥855.5bJP¥176.5b-JP¥24,974,270,000.0048.2x-34.3x4.8x
Sat, 24 Sep 2022JP¥866.5bJP¥176.5b-JP¥24,974,270,000.0044.2x-34.7x4.9x
Mon, 22 Aug 2022JP¥959.9bJP¥174.4b-JP¥21,144,270,000.0021.8x-45.4x5.5x
Wed, 20 Jul 2022JP¥944.8bJP¥171.3b-JP¥16,112,943,000.0021.3x-58.6x5.5x
Fri, 17 Jun 2022JP¥832.3bJP¥171.3b-JP¥16,658,721,000.0021.3x-50x4.9x
Sun, 15 May 2022JP¥937.9bJP¥169.1b-JP¥12,813,215,000.0012x-73.2x5.5x
Tue, 12 Apr 2022JP¥1.1tJP¥164.2b-JP¥13,043,295,000.0015.2x-82.2x6.5x
Thu, 10 Mar 2022JP¥983.5bJP¥164.1b-JP¥9,674,798,000.0014.5x-101.7x6x
Sat, 05 Feb 2022JP¥1.0tJP¥163.7b-JP¥5,383,446,000.0016.1x-193.5x6.4x
Mon, 03 Jan 2022JP¥1.2tJP¥163.5b-JP¥5,447,524,000.0018.4x-226x7.5x
Wed, 01 Dec 2021JP¥1.3tJP¥159.5b-JP¥8,763,358,000.00n/a-145.3x8x
Fri, 29 Oct 2021JP¥1.4tJP¥147.6b-JP¥12,269,440,000.0023.4x-112.2x9.3x
Sun, 26 Sep 2021JP¥1.6tJP¥147.6b-JP¥12,269,440,000.0026.1x-133.3x11.1x
Tue, 24 Aug 2021JP¥1.7tJP¥148.3b-JP¥14,096,440,000.0024.7x-117.2x11.1x
Wed, 30 Jun 2021JP¥1.9tJP¥139.5b-JP¥15,500,440,000.0033.2x-122.9x13.7x
Sat, 03 Apr 2021JP¥1.9tJP¥122.0b-JP¥18,475,632,000.0061.1x-102.2x15.5x
Tue, 05 Jan 2021JP¥1.8tJP¥103.8b-JP¥25,953,087,000.00125.6x-68.8x17.2x
Fri, 09 Oct 2020JP¥1.9tJP¥84.8b-JP¥26,206,135,000.00146.4x-74.2x22.9x
Thu, 02 Jul 2020JP¥1.9tJP¥78.3b-JP¥27,486,602,000.00139.8x-68.1x23.9x
Sun, 05 Apr 2020JP¥1.2tJP¥78.5b-JP¥32,046,297,000.00178x-38.1x15.6x
Price to Earnings Ratio

-51.2x


Total Market Cap: JP¥1.6tTotal Earnings: -JP¥30,683,316,000.00Total Revenue: JP¥77.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -82.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Japanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 12.2x is higher than the industry's current PS ratio of 5.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 34% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.51%
Healthcare-3.11%
Biotech-0.64%
Biotech-0.64%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4575 CanBasJP¥1.70k37.7%
+JP¥7.4b
628.3%PB20.9x
4591 RibomicJP¥202.009.2%
+JP¥606.8m
0%PS92.4x
2160 GNI GroupJP¥1.23k1.0%
+JP¥569.8m
6.5%PE68.7x
4884 Kringle PharmaJP¥732.005.2%
+JP¥193.7m
13.8%PS10.1x
7774 Japan Tissue EngineeringJP¥506.000.6%
+JP¥121.8m
0%PS10.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2929

JP¥1,336.00

Pharma Foods International

7D

0.2%

1Y

-19.8%

4592

JP¥755.00

SanBio

7D

-1.3%

1Y

-31.2%

7774

JP¥506.00

Japan Tissue Engineering

7D

0.6%

1Y

0%

4587

JP¥1,998.00

PeptiDream

7D

-1.7%

1Y

-3.6%

4884

JP¥732.00

Kringle Pharma

7D

5.2%

1Y

13.8%

4593

JP¥315.00

Healios K.K

7D

-4.0%

1Y

-70.1%

4594

JP¥159.00

BrightPath Biotherapeutics

7D

-18.0%

1Y

57.4%

2160

JP¥1,227.00

GNI Group

7D

1.0%

1Y

6.5%

4974

JP¥1,726.00

Takara Bio

7D

-0.2%

1Y

-25.1%

2342

JP¥348.00

Trans Genic

7D

1.5%

1Y

-18.7%

4978

JP¥294.00

ReproCELL

7D

-2.0%

1Y

36.7%

4571

JP¥206.00

NanoCarrier

7D

-11.2%

1Y

-12.0%

7777

JP¥313.00

3-D Matrix

7D

-3.1%

1Y

-27.4%

4591

JP¥202.00

Ribomic

7D

9.2%

1Y

0%

4575

JP¥1,697.00

CanBas

7D

37.7%

1Y

628.3%